CD86 and neoplasm: Furthermore, our in vitro and in vivo results demonstrated that TZ‐dSA3‐12 strongly induced the surface expression of CD80 and CD86 on DCs within the tumor microenvironment, and boosted the production of IFN‐γ and GzmB by tumor‐infiltrating CD8+ T cells.